A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab
Authors:
- 22 May 2008
- journal article
- case report
- Published by Springer Nature in Rheumatology International
- Vol. 28 (11) , 1155-1159
Abstract
We report the case of a 55-year-old Japanese woman with reactive AA amyloidosis associated with rheumatoid arthritis, in which inflammatory disease was completely suppressed with infliximab. Nephrotic syndrome was observed and renal biopsy specimens revealed amyloidosis deposits. Treatment with infliximab normalized the serum amyloid A (SAA) protein level, and subsequently nephritic syndrome disappeared and her creatinine clearance improved. Serial gastrointestinal biopsy specimens showed marked lasting regression of amyloid deposits. Thus treatment with infliximab represents an important therapeutic strategy for AA amyloidosis associated with RA.Keywords
This publication has 26 references indexed in Scilit:
- Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritisClinical Rheumatology, 2005
- Infliximab and nephrotic syndromeNephrology Dialysis Transplantation, 2005
- Etanercept treatment of renal amyloidosis complicating rheumatoid arthritisInternal Medicine Journal, 2004
- Anti–tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacyArthritis & Rheumatism, 2003
- Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximabArthritis & Rheumatism, 2002
- Drug-induced systemic lupus erythematosus associated with etanercept therapyThe Lancet, 2002
- The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial CellsJournal of Biological Chemistry, 2000
- Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosisNature Medicine, 2000
- New approaches to modify glomerular inflammation.1999
- Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiencyClinical Rheumatology, 1987